Titan Biotech Quarterly Results for Trading Insights
In Mar 2026, Titan Biotech (TITANBIO) reported revenue ₹51 Cr and net profit ₹7 Cr — revenue +37.8% YoY. Browse TITANBIO financial statements for revenue, profit, balance sheet and cash flow data.
TITANBIO Quarterly Results — Revenue, Profit & EPS Highlights
Titan Biotech latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore TITANBIO share price data to track price trends across different timeframes.
- Revenue of ₹51 Cr in Mar 2026 (-8.9% vs Sept 2025, +37.8% vs Mar 2025)
- Net Profit of ₹7 Cr in Mar 2026 (-12.5% vs Sept 2025, +75.0% vs Mar 2025)
- EBITDA of ₹12 Cr in Mar 2026 (+9.1% vs Sept 2025)
- Operating Margin of 20.0% in Mar 2026 (+3.0pp vs Sept 2025)
- Earnings Per Share of ₹1.63 in Mar 2026 (-82.7% vs Sept 2025)
Titan Biotech Quarterly Results — Revenue, EBITDA, Net Profit & EPS
TITANBIO quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 51 | 56 | 37 | 47 | 58 | -8.9% | 37.8% |
| Net Profit (₹ Cr) | 7 | 8 | 4 | 7 | 9 | - | - |
| EBITDA (₹ Cr) | 12 | 11 | 6 | 10 | 12 | - | - |
| EPS (₹) | 1.63 | 9.40 | 4.90 | 8.30 | 10.32 | - | - |
| Operating Margin (%) | 20.0% | 17.0% | 13.0% | 19.0% | 19.0% | - | - |
TITANBIO Share Price Trend — 1-Year Movement Across Quarterly Results
Titan Biotech 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit Titan Biotech share price screener.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
TITANBIO vs Chemicals Peers — Quarterly Revenue, Profit & Market Cap
Titan Biotech latest quarter revenue and net profit vs Chemicals competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Pidilite Industries
Mar 2026 |
₹163,719.34 Cr | 1570.9 | 3,648 | 584 | +1.2% | +13.2% | 16.0% | 276.1 |
|
SRF
Mar 2026 |
₹81,872.54 Cr | 2664.7 | 4,557 | 582 | +28.0% | +7.2% | 12.8% | 135.7 |
|
Coromandel Internat…
Mar 2026 |
₹60,014.83 Cr | 1980.8 | 6,068 | 115 | -37.9% | +11.1% | 1.9% | 417.0 |
|
Linde
Mar 2026 |
₹59,771.45 Cr | 6731.0 | 621 | 77 | -4.5% | +2.6% | 12.4% | 741.3 |
|
Fertilisers & Chemi…
Sept 2025 |
₹52,674.89 Cr | 809.3 | 1,681 | 21 | +48.8% | - | 1.2% | 2529.1 |
All amounts in ₹ Crores